Metabolic Diseases in Sheep: Clinical Recognition and Treatment

This article provides clinical guidance for veterinarians and sheep producers on the recognition, diagnosis, and treatment of the three most common metabolic diseases in sheep: pregnancy toxemia, hypocalcemia, and hypomagnesemia. The focus is on practical clinical decision-making, diagnostic differentiation, and treatment protocols based on current veterinary evidence.

At a Glance: Key Features of Major Metabolic Diseases in Sheep

Clinical Context and Disease Overview

Metabolic diseases in sheep represent a significant cause of morbidity and mortality in commercial flocks worldwide. A retrospective study of sheep diseases in Jordan from 2015 to 2021 identified metabolic disorders among the common conditions affecting sheep populations, highlighting their clinical importance across different production systems. The three primary metabolic diseases encountered in sheep practice are pregnancy toxemia, hypocalcemia, and hypomagnesemia, each with distinct pathophysiology, risk factors, and clinical presentations.

Pregnancy toxemia, also known as ovine ketosis, occurs primarily in late gestation when energy demands of multiple fetuses exceed maternal glucose supply. The condition reflects a failure of metabolic adaptation to the negative energy balance of late pregnancy. Hypocalcemia, or milk fever, results from acute calcium deficiency around parturition and early lactation when calcium demands for colostrum and milk production overwhelm homeostatic mechanisms. Hypomagnesemia, or grass tetany, develops when dietary magnesium intake is insufficient to meet metabolic requirements, typically in lactating ewes grazing lush, fast-growing pastures.

The clinical differentiation of these conditions requires careful history-taking, physical examination, and selective laboratory testing. The Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia provides a comprehensive framework for managing these conditions in clinical practice. Early recognition and prompt treatment are essential for favorable outcomes, as advanced cases carry poor prognoses.

Pregnancy Toxemia: Pathophysiology and Risk Factors

Pregnancy toxemia develops when the energy demands of late gestation, particularly in ewes carrying multiple fetuses, exceed the capacity of gluconeogenesis to maintain blood glucose levels. The condition is fundamentally a disorder of energy metabolism in which the ewe enters a state of negative energy balance, leading to mobilization of body fat reserves and subsequent ketone body production.

The pathophysiology involves several interconnected metabolic pathways. As glucose supply to the gravid uterus increases in late pregnancy, the ewe's liver must increase gluconeogenesis to meet demand. When dietary energy intake is insufficient, adipose tissue lipolysis releases non-esterified fatty acids, which the liver converts to ketone bodies including beta-hydroxybutyrate and acetoacetate. Excessive ketone production overwhelms peripheral utilization capacity, leading to ketonemia, ketonuria, and clinical signs of toxemia.

Risk factors for pregnancy toxemia include:

• Multiple fetuses (twins, triplets, or more)
• Poor body condition at breeding (overconditioned or underconditioned)
• Inadequate nutrition in late gestation
• Sudden feed changes or feed restriction
• Concurrent disease or lameness
• Stress from transport, weather, or handling
• Advanced age in ewes

The condition is most commonly observed in the final 4 to 6 weeks of gestation when fetal growth accelerates dramatically. Ewes carrying multiple lambs have proportionally higher energy requirements and are at greatest risk. Overconditioned ewes with excessive body fat are particularly susceptible because their adipose tissue is more metabolically active and prone to excessive lipolysis during negative energy balance.

Clinical Recognition of Pregnancy Toxemia

The clinical presentation of pregnancy toxemia ranges from subtle behavioral changes to severe neurologic dysfunction and recumbency. Early signs include depression, reduced appetite, and separation from the flock. Affected ewes may appear dull, stand with their head down, and show decreased interest in feed. As the condition progresses, owners may observe teeth grinding, muscle tremors, and a characteristic sweet or fruity odor on the breath from ketone production.

Advanced cases present with more severe neurologic signs including blindness, head pressing, circling, and eventually recumbency. Once a ewe becomes recumbent and unable to rise, the prognosis becomes guarded to poor. The Clinical findings and differential diagnosis in ketosis and hypocalcaemia of sheep provides important guidance on distinguishing pregnancy toxemia from hypocalcemia, as both conditions can present with recumbency in periparturient ewes.

Key clinical observations that support a diagnosis of pregnancy toxemia include:

• History of late gestation (last 4-6 weeks)
• Multiple fetuses confirmed by ultrasound or palpation
• Poor body condition or excessive fat cover
• Recent stress or feed change
• Ketonuria detected on urine dipstick
• Sweet or fruity breath odor
• Absence of response to calcium therapy

The clinical course can progress over several days, and early intervention significantly improves outcomes. Ewes that are still standing and eating have a much better prognosis than those that are recumbent and anorexic.

Diagnostic Confirmation of Pregnancy Toxemia

Definitive diagnosis of pregnancy toxemia relies on demonstration of ketonemia or ketonuria in a ewe with compatible clinical signs and appropriate risk factors. Blood beta-hydroxybutyrate concentration is the most reliable diagnostic test, with levels above 1.2 mmol/L indicating subclinical ketosis and levels above 2.5 mmol/L consistent with clinical pregnancy toxemia.

Urine ketone testing using commercial dipsticks provides a practical field diagnostic tool. Fresh urine samples can be collected by free catch or manual bladder expression. A positive ketone reading on the dipstick supports the diagnosis, though false negatives can occur with dilute urine or early disease.

Blood glucose measurement can be helpful, as hypoglycemia is common in pregnancy toxemia. However, glucose levels can be variable and may be normal in early cases or in ewes that have recently eaten. Serum biochemistry panels can assess liver function and electrolyte status, which may be abnormal in advanced cases.

Differential diagnoses that must be considered include:

• Hypocalcemia (may coexist with pregnancy toxemia)
• Hypomagnesemia
• Listeriosis and other central nervous system infections
• Polioencephalomalacia
• Hepatic encephalopathy from liver disease
• Toxicity from plants or other agents

The Liver diseases of sheep and goats provides context for considering hepatic causes of neurologic signs in sheep. In cases where the diagnosis remains uncertain after initial assessment, blood sampling for comprehensive metabolic profiling is warranted before initiating treatment.

Treatment Protocols for Pregnancy Toxemia

Treatment of pregnancy toxemia focuses on correcting the energy deficit, providing glucose support, and managing complications. The specific treatment approach depends on the severity of clinical signs and the stage of pregnancy.

For ewes that are still standing and eating, oral energy supplementation is the first-line treatment. Propylene glycol administered orally at appropriate doses provides a gluconeogenic substrate that can help correct hypoglycemia and reduce ketone production. Glycerol and molasses are alternative energy sources that can be used. Affected ewes should be offered high-quality hay and concentrate feed to encourage voluntary intake.

For recumbent or severely affected ewes, intravenous glucose administration is indicated. A solution of dextrose should be administered slowly intravenously to avoid rebound hypoglycemia. Following initial glucose therapy, continued oral energy supplementation with propylene glycol or glycerol is necessary to maintain blood glucose levels.

Supportive care includes:

• Providing a comfortable, dry environment with good footing
• Ensuring access to fresh water and palatable feed
• Administering B-complex vitamins to support energy metabolism
• Monitoring for complications such as aspiration pneumonia
• Assessing fetal viability when possible

In cases where medical treatment fails or the ewe continues to deteriorate, induction of parturition or cesarean section may be considered to remove the metabolic demand of the fetuses. This decision must be made early in the disease course, as advanced cases carry high surgical risk and poor fetal survival.

The prognosis for pregnancy toxemia depends on the severity of clinical signs at presentation and the response to treatment. Ewes that are still standing and eating have a good prognosis with appropriate therapy. Recumbent ewes that do not respond within 24 to 48 hours of treatment have a guarded to poor prognosis.

Hypocalcemia: Pathophysiology and Risk Factors

Hypocalcemia in sheep, analogous to milk fever in dairy cattle, results from acute calcium deficiency around the time of parturition and early lactation. The condition occurs when the demand for calcium for colostrum and milk production exceeds the ewe's ability to mobilize calcium from bone and absorb calcium from the intestine.

The pathophysiology involves disruption of calcium homeostasis. During late pregnancy and early lactation, the ewe loses significant amounts of calcium in colostrum and milk. To maintain blood calcium levels, the ewe must increase intestinal absorption of dietary calcium and mobilize calcium from bone stores, processes regulated by parathyroid hormone and vitamin D. When these homeostatic mechanisms fail, blood calcium levels fall, leading to neuromuscular dysfunction.

Risk factors for hypocalcemia include:

• First lactation or advanced age
• High milk production
• Diets high in potassium or low in calcium
• Feeding of calcium-rich feeds before parturition
• Stress from transport, weather, or handling
• Concurrent disease
• Feeding of beet tops or other oxalate-containing feeds

The Hypocalcaemia in Ossimi sheep associated with feeding on beet tops (Beta vulgaris) demonstrates that dietary factors can precipitate hypocalcemia in susceptible sheep. Beet tops contain oxalates that bind calcium and reduce its availability, potentially triggering acute hypocalcemia in lactating ewes.

The condition most commonly occurs within the first few days after lambing but can occur in late pregnancy or during lactation. Ewes with heavy milking ability are at increased risk, as are those carrying multiple lambs.

Clinical Recognition of Hypocalcemia

The clinical presentation of hypocalcemia in sheep is characterized by progressive neuromuscular dysfunction. Early signs include restlessness, muscle tremors, and a stiff, stilted gait. Affected ewes may appear anxious, grind their teeth, and show reduced appetite.

As hypocalcemia worsens, ewes become ataxic and eventually recumbent. A classic sign is the ewe lying in sternal recumbency with the head turned back toward the flank, though this position is not pathognomonic and can occur in other conditions. The Hypocalcaemia in the ewe provides clinical descriptions of the condition in affected animals.

Key clinical observations that support a diagnosis of hypocalcemia include:

• Recent parturition (within days)
• High milk production
• Progressive weakness and recumbency
• Muscle tremors and fasciculations
• Head turned to flank in recumbent ewe
• Normal mentation initially (ewe is bright but unable to rise)
• Rapid response to calcium therapy

The condition must be differentiated from pregnancy toxemia, hypomagnesemia, and physical injuries such as pelvic fracture or nerve damage. The 3 sheep with locomotor disorders provides context for considering musculoskeletal causes of recumbency in sheep.

Diagnostic Confirmation of Hypocalcemia

Definitive diagnosis of hypocalcemia requires demonstration of low blood calcium concentration. Total serum calcium levels below 8 mg/dL (2 mmol/L) are consistent with hypocalcemia, with clinical signs typically appearing at levels below 6 mg/dL (1.5 mmol/L).

In field settings, response to calcium therapy is often used as a diagnostic test. Ewes with hypocalcemia typically show dramatic improvement within 30 to 60 minutes of calcium administration. Lack of response to calcium therapy should prompt consideration of alternative diagnoses or concurrent conditions.

Blood samples for calcium measurement should be collected before treatment when possible. Serum or plasma can be used, and samples should be handled carefully to avoid hemolysis, which can interfere with calcium measurement. Ionized calcium measurement provides a more accurate assessment of physiologically active calcium but is not routinely available in field practice.

Differential diagnoses that must be considered include:

• Pregnancy toxemia (may coexist with hypocalcemia)
• Hypomagnesemia
• Physical injury (pelvic fracture, nerve damage)
• Toxicity
• Infectious disease (mastitis, metritis with toxemia)

The Clinical findings and differential diagnosis in ketosis and hypocalcaemia of sheep emphasizes the importance of distinguishing between these two common metabolic conditions, as treatment approaches differ.

Treatment Protocols for Hypocalcemia

Treatment of hypocalcemia in sheep involves administration of calcium salts to rapidly correct the calcium deficit. Calcium borogluconate is the preferred formulation and can be administered intravenously, subcutaneously, or by a combination of routes depending on the severity of clinical signs.

For recumbent ewes with severe hypocalcemia, slow intravenous administration of calcium borogluconate solution is indicated. The solution should be warmed to body temperature and administered slowly while monitoring heart rate and rhythm. Cardiac monitoring is ideal, but in field settings, careful observation for signs of cardiac toxicity including bradycardia or arrhythmia is essential. If heart rate slows or rhythm becomes irregular, administration should be paused until heart rate normalizes.

For ewes that are standing but showing clinical signs, subcutaneous administration of calcium borogluconate is appropriate. The solution should be divided among multiple injection sites to improve absorption and reduce tissue irritation. Subcutaneous calcium can cause tissue necrosis if concentrated solutions are used or if injection technique is poor.

Following initial calcium therapy, oral calcium supplementation may be necessary to maintain blood calcium levels. Calcium-containing drenches or feed additives can be used for this purpose. Ewes should be monitored for recurrence of clinical signs, as some animals require repeated calcium administration.

The Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia provides detailed protocols for calcium therapy in sheep. The prognosis for hypocalcemia is generally good with prompt treatment, and most ewes show rapid improvement within hours of calcium administration.

Hypomagnesemia: Pathophysiology and Risk Factors

Hypomagnesemia, commonly called grass tetany or grass staggers, results from inadequate magnesium intake relative to metabolic requirements. Magnesium is essential for normal neuromuscular function, and deficiency leads to hyperexcitability, tetany, and seizures.

The pathophysiology involves disruption of magnesium homeostasis. Magnesium is absorbed from the rumen and small intestine, and absorption efficiency is influenced by dietary factors including potassium and nitrogen content. High-potassium forages reduce magnesium absorption, while high-energy feeds improve it. Lactating ewes have increased magnesium requirements for milk production, making them particularly susceptible to deficiency.

Risk factors for hypomagnesemia include:

• Spring turnout on lush, fast-growing pasture
• Pastures heavily fertilized with nitrogen and potassium
• Cold, wet weather that reduces feed intake
• Lactation (increased magnesium demand)
• Stress from transport or handling
• Concurrent disease
• Diets low in magnesium or high in potassium

The condition most commonly occurs in lactating ewes grazing lush spring pastures, particularly when weather conditions are cold and wet. The rapid growth of grass in spring results in low magnesium content and high potassium content, which reduces magnesium absorption. Cold stress further increases magnesium requirements and reduces feed intake, creating conditions that predispose to hypomagnesemia.

Clinical Recognition of Hypomagnesemia

The clinical presentation of hypomagnesemia is characterized by neuromuscular hyperexcitability. Early signs include restlessness, muscle fasciculations, and a stiff, stilted gait. Affected ewes may appear nervous, hold their head high, and show increased sensitivity to sound and touch.

As magnesium deficiency worsens, ewes develop tetany with rigid extension of the limbs and opisthotonos. Seizures may occur, and affected animals may collapse and paddle. Without treatment, progression to coma and death can occur rapidly, often within hours of the onset of clinical signs.

Key clinical observations that support a diagnosis of hypomagnesemia include:

• History of grazing lush spring pasture
• Lactating ewes
• Cold, wet weather
• Hyperesthesia and muscle fasciculations
• Tetany and seizures
• Rapid progression of clinical signs
• Poor response to calcium therapy alone

The condition must be differentiated from hypocalcemia, pregnancy toxemia, and central nervous system infections. The rapid progression and dramatic neurologic signs of hypomagnesemia are distinctive, but concurrent hypocalcemia is common and can complicate the clinical picture.

Diagnostic Confirmation of Hypomagnesemia

Definitive diagnosis of hypomagnesemia requires demonstration of low blood magnesium concentration. Serum magnesium levels below 1.5 mg/dL (0.6 mmol/L) are consistent with hypomagnesemia, with clinical signs typically appearing at levels below 1.0 mg/dL (0.4 mmol/L).

Blood samples for magnesium measurement should be collected before treatment when possible. Serum or plasma can be used, and samples should be handled carefully to avoid hemolysis. Magnesium measurement is not routinely available in field practice, and diagnosis often relies on clinical presentation and response to treatment.

In field settings, response to magnesium therapy is often used as a diagnostic test. Ewes with hypomagnesemia typically show improvement within 30 to 60 minutes of magnesium administration, though complete recovery may take longer. Lack of response to magnesium therapy should prompt consideration of alternative diagnoses.

Differential diagnoses that must be considered include:

• Hypocalcemia (commonly coexists with hypomagnesemia)
• Pregnancy toxemia
• Listeriosis and other central nervous system infections
• Polioencephalomalacia
• Toxicity from plants or other agents

The Metabolic disruption identified in the Huntington's disease transgenic sheep model provides context for understanding metabolic disturbances that can affect neurologic function in sheep, though this is not directly relevant to clinical hypomagnesemia.

Treatment Protocols for Hypomagnesemia

Treatment of hypomagnesemia involves administration of magnesium salts to correct the magnesium deficit. Magnesium sulfate is the most commonly used formulation and can be administered intravenously, subcutaneously, or by a combination of routes depending on the severity of clinical signs.

For recumbent ewes with severe hypomagnesemia, slow intravenous administration of magnesium sulfate solution is indicated. The solution should be administered slowly while monitoring for signs of magnesium toxicity including respiratory depression and cardiac arrhythmia. Calcium and magnesium solutions are often combined for treatment of concurrent hypocalcemia and hypomagnesemia.

For ewes that are standing but showing clinical signs, subcutaneous administration of magnesium sulfate is appropriate. The solution should be divided among multiple injection sites to improve absorption and reduce tissue irritation. Oral magnesium supplementation can be used for prevention and for mild cases.

Following initial magnesium therapy, continued magnesium supplementation is necessary to prevent recurrence. Oral magnesium oxide or magnesium sulfate can be added to feed or water. Pasture management including avoiding lush spring pastures and providing magnesium supplements during high-risk periods is essential for prevention.

The Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia provides detailed protocols for magnesium therapy in sheep. The prognosis for hypomagnesemia depends on the severity of clinical signs at presentation and the speed of treatment. Ewes treated early in the disease course have a good prognosis, while those with advanced tetany or seizures have a guarded prognosis.

Differential Diagnosis of Metabolic Diseases

Accurate differentiation of the three major metabolic diseases is essential for appropriate treatment. The Clinical findings and differential diagnosis in ketosis and hypocalcaemia of sheep provides important guidance on distinguishing these conditions in clinical practice.

Key differentiating features include:

• Pregnancy toxemia: Late gestation, multiple fetuses, ketotic breath, ketonuria, depression, blindness, slow progression over days
• Hypocalcemia: Periparturient period, progressive weakness, recumbency with head turned to flank, normal mentation, rapid response to calcium
• Hypomagnesemia: Lactating ewes on lush pasture, hyperesthesia, tetany, seizures, rapid progression over hours

Concurrent metabolic disease is common, and ewes may present with mixed clinical signs. In cases where the diagnosis is uncertain, treatment should address the most likely condition first, with careful monitoring of response. If response to initial treatment is inadequate, additional therapy for alternative diagnoses should be considered.

Laboratory testing is valuable for definitive diagnosis but should not delay treatment in acute cases. Blood samples should be collected before treatment when possible, and results can guide ongoing management.

Prevention Strategies for Metabolic Diseases

Prevention of metabolic diseases in sheep requires attention to nutrition, management, and risk factor identification. The World Organisation for Animal Health provides guidance on animal health and welfare that is relevant to preventing metabolic disease through good management practices.

Key prevention strategies include:

• Body condition scoring and management: Ewes should be in moderate body condition (score 3 out of 5) at breeding and throughout pregnancy. Overconditioned and underconditioned ewes are at increased risk for metabolic disease.
• Nutritional management in late gestation: Energy intake should be increased in the final 4 to 6 weeks of pregnancy to meet the demands of fetal growth. High-quality forage and concentrate supplementation may be necessary.
• Calcium nutrition: Diets should be balanced for calcium content, and calcium supplementation should be provided around parturition. Avoiding high-calcium diets before parturition may reduce the risk of hypocalcemia.
• Magnesium supplementation: Magnesium supplements should be provided to lactating ewes grazing lush spring pastures. Magnesium oxide can be added to feed, or magnesium bullets can be administered.
• Pasture management: Avoiding lush, fast-growing pastures for lactating ewes reduces the risk of hypomagnesemia. Pastures should be managed to maintain appropriate potassium and nitrogen levels.
• Stress reduction: Minimizing stress from transport, handling, weather, and concurrent disease reduces the risk of metabolic disease. Providing shelter and appropriate stocking density is important.

The Prenatal Steroids and Metabolic Dysfunction: Lessons from Sheep provides insights into how early-life factors can influence metabolic health in sheep, though this research is not directly applicable to clinical prevention strategies.

Records and Monitoring

Maintaining accurate records is essential for identifying risk factors and monitoring the effectiveness of prevention programs. Key records that should be maintained include:

• Flock health records documenting cases of metabolic disease
• Body condition scores at breeding, mid-pregnancy, and pre-lambing
• Lambing records including number of lambs born and any complications
• Feed analysis results including energy, protein, calcium, magnesium, and potassium content
• Pasture management records including fertilization and grazing history
• Treatment records including drugs administered, doses, and outcomes

Monitoring programs should include regular body condition scoring, assessment of feed quality, and observation of ewes for early signs of metabolic disease. Urine ketone testing can be used to screen high-risk ewes in late gestation.

Common Failure Patterns in Treatment

Several common failure patterns can compromise treatment of metabolic diseases in sheep. Recognizing these patterns allows veterinarians to adjust treatment protocols and improve outcomes.

Failure pattern 1: Delayed treatment. Metabolic diseases progress rapidly, and delayed treatment significantly worsens prognosis. Ewes that are recumbent for more than 24 hours have a poor prognosis regardless of the specific condition.

Failure pattern 2: Inadequate dose or route of administration. Underdosing of calcium or magnesium is common, particularly when using subcutaneous administration. Intravenous administration is necessary for recumbent ewes with severe disease.

Failure pattern 3: Failure to address concurrent disease. Hypocalcemia and hypomagnesemia commonly coexist, and treatment of only one condition may result in incomplete recovery. Combined calcium-magnesium solutions are appropriate when both deficiencies are suspected.

Failure pattern 4: Inadequate supportive care. Recumbent ewes require careful nursing care including provision of comfortable bedding, regular turning to prevent pressure sores, and assistance with eating and drinking.

Failure pattern 5: Failure to address underlying causes. Treatment of acute metabolic disease must be accompanied by correction of underlying nutritional and management factors to prevent recurrence.

Professional Escalation Criteria

Veterinarians should recognize situations that require escalation of care or referral to specialized facilities. Criteria for escalation include:

• Ewes that do not respond to initial treatment within 24 hours
• Recumbent ewes that cannot rise after 48 hours of treatment
• Ewes with severe neurologic signs including seizures or coma
• Ewes with suspected concurrent disease such as pneumonia or mastitis
• Cases where the diagnosis remains uncertain after initial assessment
• Flocks with multiple cases of metabolic disease suggesting a systemic management problem

In these situations, additional diagnostic testing including comprehensive blood work, assessment of fetal viability, and evaluation for concurrent disease is warranted. Referral to a veterinary teaching hospital or specialty practice may be appropriate for complex cases.

Practical Decision Framework for Differentiating Metabolic Diseases in Sheep

Accurate differentiation of pregnancy toxemia, hypocalcemia, and hypomagnesemia is critical for selecting the correct treatment protocol and improving survival outcomes. The Clinical findings and differential diagnosis in ketosis and hypocalcaemia of sheep provides evidence that these conditions can present with overlapping clinical signs, particularly in recumbent ewes. A structured decision framework helps veterinarians and producers make rapid, evidence-based treatment choices when laboratory confirmation is not immediately available.

Step-by-Step Clinical Assessment Protocol

Begin with a focused history covering three key elements: stage of production, diet and pasture access, and progression of clinical signs. Record the ewe's stage of gestation or lactation, number of lambs carried or born, and any recent management changes. Ask about pasture type, fertilizer application, and supplemental feeding. Determine how quickly clinical signs developed and whether the ewe has been treated previously.

Perform a systematic physical examination with attention to neurologic status, posture, and response to stimuli. Assess the ewe's mentation: is she bright and alert but unable to rise, or dull and depressed? Evaluate muscle tone and presence of tremors, fasciculations, or tetany. Check for the characteristic sweet or fruity breath odor of ketosis. Observe the ewe's head position when recumbent: head turned to the flank is more consistent with hypocalcemia, while head pressing or blindness suggests pregnancy toxemia.

Test urine for ketones using a commercial dipstick. Collect a fresh urine sample by free catch or manual bladder expression. A positive ketone reading supports pregnancy toxemia, though false negatives can occur in early disease or with dilute urine. Blood glucose measurement using a handheld glucometer provides additional information: hypoglycemia supports pregnancy toxemia, while normal or elevated glucose is more consistent with hypocalcemia or hypomagnesemia.

Decision Matrix for Treatment Selection

Use the following matrix to guide initial treatment decisions based on clinical presentation:

The Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia provides detailed protocols for administering these treatments. When the diagnosis is uncertain, treat the most life-threatening condition first. Hypomagnesemia progresses most rapidly and carries the highest immediate mortality risk, so it should be prioritized when tetany or seizures are present.

Response Monitoring and Treatment Adjustment

After administering initial treatment, monitor the ewe closely for 30 to 60 minutes. Document the time of treatment, dose administered, and route of administration. Assess the ewe's response using the following criteria:

• Complete response: Ewe stands and resumes normal behavior within 60 minutes. This is most consistent with uncomplicated hypocalcemia or hypomagnesemia.
• Partial response: Ewe improves but remains weak or recumbent. This may indicate concurrent metabolic disease, inadequate dosing, or an alternative diagnosis.
• No response: Ewe shows no improvement within 60 minutes. This suggests an incorrect diagnosis, advanced disease with irreversible tissue damage, or a non-metabolic condition.

For ewes with partial or no response, reassess the history and clinical findings. Consider collecting blood samples for laboratory analysis before administering additional treatment. If hypocalcemia was suspected but the ewe did not respond to calcium, consider adding magnesium therapy. If pregnancy toxemia was suspected but the ewe did not respond to glucose, evaluate for concurrent hypocalcemia or consider surgical intervention.

Record System for Metabolic Disease Cases

Maintain a standardized record for each metabolic disease case to track treatment outcomes and identify flock-level risk factors. Include the following fields:

• Ewe identification number and age
• Body condition score at diagnosis
• Stage of production (days before or after lambing)
• Number of lambs carried or born
• Clinical signs at presentation (checklist: depression, anorexia, blindness, recumbency, tremors, tetany, seizures, head position)
• Urine ketone result (positive or negative)
• Blood glucose level if measured
• Presumptive diagnosis
• Treatment administered (drug, dose, route, time)
• Response to treatment (complete, partial, none at 60 minutes)
• Final outcome (recovered, died, euthanized)
• Necropsy findings if applicable

Review records quarterly to identify patterns. A cluster of hypomagnesemia cases in lactating ewes on a particular pasture indicates a need for magnesium supplementation or pasture management changes. Multiple pregnancy toxemia cases in overconditioned ewes carrying twins suggests a need for body condition management and nutritional adjustment in late gestation.

Troubleshooting Common Diagnostic Challenges

Challenge 1: The ewe is recumbent with mixed signs including depression and muscle tremors. This presentation is common when hypocalcemia and pregnancy toxemia coexist. Treat with combined calcium and glucose therapy. Administer calcium borogluconate intravenously and provide oral propylene glycol. Monitor for response over 60 minutes and adjust treatment accordingly.

Challenge 2: The ewe has tetany but is in late gestation instead of lactation. While hypomagnesemia is most common in lactating ewes on lush pasture, it can occur in late gestation if magnesium intake is severely deficient. Consider hypomagnesemia even in pregnant ewes if they are on low-magnesium feed or stressed by cold weather. The Hypocalcaemia in Ossimi sheep associated with feeding on beet tops (Beta vulgaris) demonstrates that dietary factors can precipitate metabolic disease in unexpected production stages.

Challenge 3: The ewe responds partially to calcium but relapses within 12 to 24 hours. This pattern suggests inadequate initial dosing, concurrent hypomagnesemia impairing calcium metabolism, or an underlying condition such as mastitis or metritis that is contributing to metabolic disturbance. Re-treat with calcium, add magnesium therapy, and perform a thorough physical examination for concurrent disease.

Challenge 4: Multiple ewes in the flock develop metabolic disease within a short period. This indicates a flock-level problem such as inadequate nutrition, poor feed quality, or inappropriate pasture management. Investigate feed analysis, pasture composition, and body condition scores across the flock. The World Organisation for Animal Health provides guidance on animal health and welfare that emphasizes the importance of addressing systemic management issues when disease clusters occur.

Limitations of Field Diagnosis

Field diagnosis of metabolic diseases has inherent limitations that veterinarians must recognize. Clinical signs overlap significantly, and concurrent metabolic disease is common. Laboratory confirmation is not always available in field settings, and treatment decisions must often be made based on clinical assessment alone.

Response to treatment is a useful diagnostic tool but is not definitive. Ewes with hypocalcemia may respond partially to calcium even if the primary problem is hypomagnesemia, because calcium administration can temporarily improve neuromuscular function. Conversely, ewes with pregnancy toxemia may show transient improvement with glucose therapy even if the underlying energy deficit is not fully corrected.

Blood sampling before treatment is ideal but may not be practical in all situations. When possible, collect serum or plasma samples for calcium, magnesium, and beta-hydroxybutyrate measurement before administering any treatment. Store samples appropriately and submit to a diagnostic laboratory for analysis. Results can confirm the diagnosis and guide ongoing management, even if treatment has already been initiated.

Professional Escalation Criteria

Recognize situations that require escalation of care beyond initial field treatment. Escalate when:

• The ewe shows no response to appropriate treatment within 60 minutes
• The ewe remains recumbent after 24 hours of treatment
• Severe neurologic signs including seizures or coma are present
• Multiple ewes in the flock are affected simultaneously
• The diagnosis remains uncertain after initial assessment and response monitoring
• Concurrent disease such as pneumonia, mastitis, or metritis is suspected

In these situations, collect comprehensive blood samples for metabolic profiling, complete blood count, and serum biochemistry. Evaluate fetal viability using ultrasound if pregnancy toxemia is suspected. Consider referral to a veterinary teaching hospital or specialty practice for advanced diagnostic testing and intensive care.

The Liver diseases of sheep and goats provides context for considering hepatic causes of metabolic disturbance in cases that do not respond to standard treatment. Hepatic lipidosis can complicate pregnancy toxemia and worsen prognosis. Ewes with severe hepatic involvement may require more aggressive supportive care and have a poorer prognosis for recovery.

Frequently Asked Questions

What is the most common metabolic disease in sheep?

Pregnancy toxemia is the most commonly diagnosed metabolic disease in sheep, particularly in flocks with intensive management and high twinning rates. The condition occurs in late gestation when energy demands of multiple fetuses exceed maternal glucose supply. A retrospective study of sheep diseases in Jordan from 2015 to 2021 identified metabolic disorders among the common conditions affecting sheep populations, with pregnancy toxemia being a frequent diagnosis in late gestation ewes.

How can I differentiate pregnancy toxemia from hypocalcemia in the field?

Differentiation relies on history, clinical signs, and response to treatment. Pregnancy toxemia typically occurs in late gestation ewes with multiple fetuses and presents with depression, anorexia, blindness, and ketotic breath. Hypocalcemia occurs around parturition and presents with progressive weakness, muscle tremors, and recumbency with the head turned to the flank. The Clinical findings and differential diagnosis in ketosis and hypocalcaemia of sheep provides guidance on distinguishing these conditions. Response to calcium therapy is rapid in hypocalcemia but absent in pregnancy toxemia.

Can hypocalcemia and hypomagnesemia occur together in sheep?

Yes, concurrent hypocalcemia and hypomagnesemia is common in sheep, particularly in lactating ewes grazing lush spring pastures. Magnesium deficiency impairs calcium metabolism, and ewes with hypomagnesemia often develop secondary hypocalcemia. Treatment should address both deficiencies using combined calcium-magnesium solutions. The Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia provides guidance on managing concurrent metabolic disease.

What is the prognosis for a recumbent ewe with pregnancy toxemia?

The prognosis for recumbent ewes with pregnancy toxemia is guarded to poor. Ewes that are still standing and eating have a good prognosis with appropriate treatment, but once recumbency develops, the likelihood of recovery decreases significantly. Ewes that do not respond to treatment within 24 to 48 hours have a very poor prognosis. Early intervention before recumbency develops is essential for favorable outcomes.

How is hypomagnesemia prevented in sheep?

Prevention of hypomagnesemia focuses on providing adequate magnesium intake during high-risk periods. Magnesium supplements including magnesium oxide added to feed or magnesium bullets administered orally can be used. Pasture management including avoiding lush, fast-growing pastures for lactating ewes and maintaining appropriate potassium and nitrogen levels in pastures reduces risk. The World Organisation for Animal Health provides guidance on animal health and welfare that is relevant to preventing metabolic disease through good management practices.

What diagnostic tests are most useful for metabolic diseases in sheep?

Blood beta-hydroxybutyrate measurement is the most reliable test for pregnancy toxemia, with levels above 1.2 mmol/L indicating subclinical ketosis and levels above 2.5 mmol/L consistent with clinical disease. Urine ketone testing using commercial dipsticks provides a practical field diagnostic tool. Blood calcium measurement confirms hypocalcemia, with levels below 8 mg/dL consistent with clinical disease. Blood magnesium measurement confirms hypomagnesemia, with levels below 1.5 mg/dL consistent with clinical disease. Response to treatment is often used as a diagnostic test in field settings.

Can metabolic diseases in sheep be treated with oral supplements alone?

Oral supplementation is appropriate for mild cases of metabolic disease in sheep that are still standing and eating. Propylene glycol administered orally is effective for pregnancy toxemia, and oral calcium and magnesium supplements can be used for mild hypocalcemia and hypomagnesemia. However, recumbent ewes with severe disease require intravenous therapy for rapid correction of metabolic deficits. The Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia provides guidance on appropriate routes of administration based on disease severity.

What are the welfare implications of metabolic diseases in sheep?

Metabolic diseases in sheep cause significant pain and distress, and prompt treatment is essential for animal welfare. The World Organisation for Animal Health provides guidance on animal health and welfare that emphasizes the importance of preventing and treating disease. Ewes with metabolic disease may experience pain from tissue damage, neurologic dysfunction, and recumbency. Untreated metabolic disease can lead to prolonged suffering and death. Prevention through good nutrition and management is the most effective approach to protecting sheep welfare.

Related Veterinary Guides

• Beef Cow Pregnancy Diagnosis Records
• Veterinary Clinical Methods Procedures Surgical Interventions
• Sheep Foot Health And Lameness Prevention
• Beef Cow Pregnancy Loss Investigation
• Goat Health Management Vaccination Biosecurity Disease Prevention

References and Further Reading

• www.acvim.org
• Merck Veterinary Manual. Merck Veterinary Manual.
• Animal Health and Welfare. World Organisation for Animal Health.
• Liver diseases of sheep and goats.. The Veterinary clinics of North America. Large animal practice, 1983.
• Prenatal Steroids and Metabolic Dysfunction: Lessons from Sheep.. Annual review of animal biosciences, 2019.
• Gut microbiota contributes to bisphenol A-induced maternal intestinal and placental apoptosis, oxidative stress, and fetal growth restriction in pregnant ewe model by regulating gut-placental axis.. Microbiome, 2024.
• Common diseases of sheep (Ovis aries Linnaeus) and goats (Capra aegagrus hircus) in Jordan: A retrospective study (2015-2021).. Open veterinary journal, 2022.
• Oxalate toxicosis.. Clinical toxicology, 1972.
• Metabolic disruption identified in the Huntington's disease transgenic sheep model.. Scientific reports, 2016.
• Clinical findings and differential diagnosis in ketosis and hypocalcaemia of sheep. Deutsche Tierarztliche Wochenschrift, 1998.
• Hypocalcaemia in Ossimi sheep associated with feeding on beet tops (Beta vulgaris). Turkish Journal of Veterinary and Animal Sciences, 2008.
• 3 sheep with locomotor disorders. Tijdschrift Voor Diergeneeskunde, 1984.
• Hypocalcaemia in the ewe.. Nordisk Veterinaermedicin, 1981.
• Treatment and Control of Peri-Parturient Metabolic Diseases: Pregnancy Toxemia, Hypocalcemia, Hypomagnesemia. Veterinary Clinics of North America Food Animal Practice, 2011.

This article is educational and is not a substitute for veterinary diagnosis or treatment. Contact a veterinarian for advice about an individual animal.